85 related articles for article (PubMed ID: 17249580)
1. Assessing the efficacy of gene therapy in Rpe65-/- mice using photoentrainment of circadian rhythm.
Stoddart CW; Yu MJ; Martin-Iverson MT; Daniels DM; Lai CM; Barnett NL; Redmond TM; Narfström K; Rakoczyt PE
Adv Exp Med Biol; 2006; 572():239-45. PubMed ID: 17249580
[No Abstract] [Full Text] [Related]
2. Rod and cone pigment regeneration in RPE65-/- mice.
Rohrer B; Crouch R
Adv Exp Med Biol; 2006; 572():101-7. PubMed ID: 17249562
[No Abstract] [Full Text] [Related]
3. Lentiviral vectors containing a retinal pigment epithelium specific promoter for leber congenital amaurosis gene therapy. Lentiviral gene therapy for LCA.
Bemelmans AP; Kostic C; Hornfeld D; Jaquet M; Crippa SV; Hauswirth WW; Lem J; Wang Z; Schorderet DE; Munier FL; Wenzel A; Arsenijevic Y
Adv Exp Med Biol; 2006; 572():247-53. PubMed ID: 17249581
[No Abstract] [Full Text] [Related]
4. Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness.
Acland GM; Aguirre GD; Bennett J; Aleman TS; Cideciyan AV; Bennicelli J; Dejneka NS; Pearce-Kelling SE; Maguire AM; Palczewski K; Hauswirth WW; Jacobson SG
Mol Ther; 2005 Dec; 12(6):1072-82. PubMed ID: 16226919
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy in the second eye of RPE65-deficient dogs improves retinal function.
Annear MJ; Bartoe JT; Barker SE; Smith AJ; Curran PG; Bainbridge JW; Ali RR; Petersen-Jones SM
Gene Ther; 2011 Jan; 18(1):53-61. PubMed ID: 20703309
[TBL] [Abstract][Full Text] [Related]
6. Lentiviral gene transfer of RPE65 rescues survival and function of cones in a mouse model of Leber congenital amaurosis.
Bemelmans AP; Kostic C; Crippa SV; Hauswirth WW; Lem J; Munier FL; Seeliger MW; Wenzel A; Arsenijevic Y
PLoS Med; 2006 Oct; 3(10):e347. PubMed ID: 17032058
[TBL] [Abstract][Full Text] [Related]
7. Entrainment of circadian rhythm to a photoperiod reversal shows retinal dystrophy in RPE65(-/-) mice.
Daniels DM; Stoddart CW; Martin-Iverson MT; Lai CM; Redmond TM; Rakoczy PE
Physiol Behav; 2003 Sep; 79(4-5):701-11. PubMed ID: 12954412
[TBL] [Abstract][Full Text] [Related]
8. Promises and challenges of genetic therapy for blindness.
Cremers FP; Collin RW
Lancet; 2009 Nov; 374(9701):1569-70. PubMed ID: 19854500
[No Abstract] [Full Text] [Related]
9. Nonvisual light responses in the Rpe65 knockout mouse: rod loss restores sensitivity to the melanopsin system.
Doyle SE; Castrucci AM; McCall M; Provencio I; Menaker M
Proc Natl Acad Sci U S A; 2006 Jul; 103(27):10432-10437. PubMed ID: 16788070
[TBL] [Abstract][Full Text] [Related]
10. Assessment of rAAV-mediated gene therapy in the Rpe65-/- mouse.
Rakoczy PE; Lai CM; Yu MJ; Daniels DM; Brankov M; Rae BC; Stoddart CW; Barnett NL; Martin-Iverson MT; Redmond TM; Narfstrom K; Zhou X; Constable IJ
Adv Exp Med Biol; 2003; 533():431-8. PubMed ID: 15180295
[No Abstract] [Full Text] [Related]
11. Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation.
Aguirre GK; Komáromy AM; Cideciyan AV; Brainard DH; Aleman TS; Roman AJ; Avants BB; Gee JC; Korczykowski M; Hauswirth WW; Acland GM; Aguirre GD; Jacobson SG
PLoS Med; 2007 Jun; 4(6):e230. PubMed ID: 17594175
[TBL] [Abstract][Full Text] [Related]
12. Focus on Molecules: RPE65, the visual cycle retinol isomerase.
Redmond TM
Exp Eye Res; 2009 May; 88(5):846-7. PubMed ID: 18762184
[No Abstract] [Full Text] [Related]
13. Opsin activation of transduction in the rods of dark-reared Rpe65 knockout mice.
Fan J; Woodruff ML; Cilluffo MC; Crouch RK; Fain GL
J Physiol; 2005 Oct; 568(Pt 1):83-95. PubMed ID: 15994181
[TBL] [Abstract][Full Text] [Related]
14. Lentiviral gene transfer-mediated cone vision restoration in RPE65 knockout mice.
Bemelmans AP; Kostic C; Cachafeiro M; Crippa SV; Wanner D; Tekaya M; Wenzel A; Arsenijevic Y
Adv Exp Med Biol; 2008; 613():89-95. PubMed ID: 18188932
[No Abstract] [Full Text] [Related]
15. The consortium project to treat RPE65 deficiency in humans.
Hauswirth WW
Retina; 2005 Dec; 25(8 Suppl):S60. PubMed ID: 16374340
[No Abstract] [Full Text] [Related]
16. Rpe65 as a modifier gene for inherited retinal degeneration.
Samardzija M; Wenzel A; Naash M; Remé CE; Grimm C
Eur J Neurosci; 2006 Feb; 23(4):1028-34. PubMed ID: 16519667
[TBL] [Abstract][Full Text] [Related]
17. Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis.
Jacobson SG; Boye SL; Aleman TS; Conlon TJ; Zeiss CJ; Roman AJ; Cideciyan AV; Schwartz SB; Komaromy AM; Doobrajh M; Cheung AY; Sumaroka A; Pearce-Kelling SE; Aguirre GD; Kaushal S; Maguire AM; Flotte TR; Hauswirth WW
Hum Gene Ther; 2006 Aug; 17(8):845-58. PubMed ID: 16942444
[TBL] [Abstract][Full Text] [Related]
18. Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency.
Pang J; Boye SE; Lei B; Boye SL; Everhart D; Ryals R; Umino Y; Rohrer B; Alexander J; Li J; Dai X; Li Q; Chang B; Barlow R; Hauswirth WW
Gene Ther; 2010 Jul; 17(7):815-26. PubMed ID: 20237510
[TBL] [Abstract][Full Text] [Related]
19. In utero gene therapy rescues vision in a murine model of congenital blindness.
Dejneka NS; Surace EM; Aleman TS; Cideciyan AV; Lyubarsky A; Savchenko A; Redmond TM; Tang W; Wei Z; Rex TS; Glover E; Maguire AM; Pugh EN; Jacobson SG; Bennett J
Mol Ther; 2004 Feb; 9(2):182-8. PubMed ID: 14759802
[TBL] [Abstract][Full Text] [Related]
20. Function of the protein RPE65 in the visual cycle.
Wolf G
Nutr Rev; 2005 Mar; 63(3):97-100. PubMed ID: 15825812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
